HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells
Christopher Butler(West Virginia School of Osteopathic Medicine), Tuoen Liu(West Virginia School of Osteopathic Medicine)
Cited by 6
Related Papers
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
|The Lancet|2021|310
Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis
|PLoS ONE|2016|28